Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.

Source:http://linkedlifedata.com/resource/pubmed/id/7571214

Download in:

View as

General Info

PMID
7571214